Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Axogen Inc (AXGN)

Axogen Inc (AXGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 577,012
  • Shares Outstanding, K 40,126
  • Annual Sales, $ 106,710 K
  • Annual Income, $ -29,140 K
  • 60-Month Beta 0.64
  • Price/Sales 5.37
  • Price/Cash Flow N/A
  • Price/Book 4.70
Trade AXGN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.17
  • Number of Estimates 1
  • High Estimate -0.17
  • Low Estimate -0.17
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +5.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.54 +24.61%
on 10/29/20
15.55 -7.52%
on 11/18/20
+1.84 (+14.67%)
since 10/27/20
3-Month
10.57 +36.05%
on 09/14/20
15.55 -7.52%
on 11/18/20
+2.86 (+24.83%)
since 08/27/20
52-Week
7.16 +100.84%
on 04/16/20
18.84 -23.67%
on 12/27/19
-2.98 (-17.19%)
since 11/27/19

Most Recent Stories

More News
Axogen, Inc. to Participate at Jefferies Virtual London Healthcare Conference and Canaccord Genuity Virtual MedTech & Diagnostics Forum

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that Karen Zaderej, chairman, CEO,...

MHMNF : 54.5000 (unch)
AXGN : 14.38 (+0.77%)
AxoGen (AXGN) Beats Q3 Earnings and Revenue Estimates

AxoGen (AXGN) delivered earnings and revenue surprises of 130.77% and 11.06%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

AXGN : 14.38 (+0.77%)
Axogen, Inc. Reports Third Quarter 2020 Financial Results

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the second...

ABMD : 271.90 (+3.06%)
AXGN : 14.38 (+0.77%)
AxoGen, Inc.to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 29, 2020 / AxoGen, Inc. (AXGN) will be discussing their earnings results in their call to be held on 10/29/2020 at 4:30:00 PM Eastern Time.

AXGN : 14.38 (+0.77%)
Axogen, Inc. to Report Third Quarter 2020 Financial Results and Host Conference Call on October 29, 2020

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today confirmed that it will report third quarter...

AXGN : 14.38 (+0.77%)
Axogen, Inc. Appoints Paul G. Thomas to Board of Directors

Healthcare veteran brings 30+ years of medtech experience to Axogen, Inc. Board of Directors

AXGN : 14.38 (+0.77%)
ABMD : 271.90 (+3.06%)
SRGA : 2.19 (+0.46%)
Axogen, Inc. to Present at the JMP Securities MedTech Bio Summit

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that Karen Zaderej, chairman, CEO,...

MHMNF : 54.5000 (unch)
AXGN : 14.38 (+0.77%)
Axogen to Participate in the 75th Annual American Society for Surgery of the Hand Meeting

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that it will participate in the 75 Annual...

AXGN : 14.38 (+0.77%)
Thinking about buying stock in AxoGen Inc, Oasis Petroleum, General Electric, Kopin Corp, or Kindred Biosciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AXGN, OAS, GE, KOPN, and KIN.

AXGN : 14.38 (+0.77%)
GE : 10.40 (-0.95%)
KIN : 3.90 (-2.50%)
OAS : 34.13 (+0.03%)
Axogen, Inc. to Present at the Cantor Virtual Global Healthcare Conference

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that Karen Zaderej, chairman, CEO,...

AXGN : 14.38 (+0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch...

See More

Key Turning Points

2nd Resistance Point 15.20
1st Resistance Point 14.79
Last Price 14.38
1st Support Level 14.06
2nd Support Level 13.74

See More

52-Week High 18.84
Fibonacci 61.8% 14.38
Last Price 14.38
Fibonacci 50% 13.00
Fibonacci 38.2% 11.62
52-Week Low 7.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar